BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+0.91%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.67B
AUM Growth
+$2.67B
(+0.03%)
Cap. Flow
+$85.3M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
54.57%
Holding
76
New
9
Increased
18
Reduced
16
Closed
6
Top Buys
| 1 |
GH Research
GHRS
|
$202M |
| 2 |
argenx
ARGX
|
$103M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$39.9M |
| 4 |
RAIN
Rain Oncology Inc. Common Stock
RAIN
|
$30.2M |
| 5 |
Janux Therapeutics
JANX
|
$29.4M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$239M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$61.3M |
| 3 |
IDEAYA Biosciences
IDYA
|
$61.3M |
| 4 |
CytomX Therapeutics
CTMX
|
$43.1M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$35.6M |
Sector Composition
| 1 | Healthcare | 98.39% |
| 2 | Financials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ovid Therapeutics
OVID
$91.7M
| $25.9M | 0.97% |
6,631,051
+213,500
| +3% | +$835K |
|
|
INFI
27
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $25.1M | 0.94% |
8,383,645
| – | – |
|
|
IMA
28
ImageneBio, Inc. Common Stock
IMA
$154M
| $24.8M | 0.93% |
1,767,399
+167,741
| +10% | +$2.35M |
|
|
MTEM
29
DELISTED
Molecular Templates, Inc.
MTEM
| $22.3M | 0.84% |
2,856,599
-7,700
| -0.3% | -$60.2K |
|
|
CTIC
30
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $22.3M | 0.84% |
8,929,690
+2,000,000
| +29% | +$5M |
|
|
CBIO
31
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $22.1M | 0.83% |
9,544,262
| – | – |
|
|
CALT
32
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $22.1M | 0.83% |
750,000
| – | – |
|
|
ELEV
33
DELISTED
Elevation Oncology
ELEV
| $21.6M | 0.81% |
+1,590,291
| New | +$21.6M |
|
34
AnaptysBio
ANAB
$614M
| $21M | 0.79% |
808,710
-380,790
| -32% | -$9.87M |
|
35
Day One Biopharmaceuticals
DAWN
$773M
| $20.9M | 0.78% |
+918,975
| New | +$20.9M |
|
|
PVLA
36
Palvella Therapeutics, Inc. Common Stock
PVLA
$579M
| $20.4M | 0.76% |
5,328,239
-166,343
| -3% | -$637K |
|
37
Forte Biosciences
FBRX
$136M
| $19.9M | 0.75% |
591,811
-126,977
| -18% | -$4.27M |
|
38
Cullinan Oncology
CGEM
$453M
| $18.9M | 0.71% |
735,106
-314,250
| -30% | -$8.09M |
|
|
NGM
39
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $18.8M | 0.71% |
+955,000
| New | +$18.8M |
|
40
Aclaris Therapeutics
ACRS
$218M
| $17.6M | 0.66% |
+1,000,000
| New | +$17.6M |
|
|
CFRX
41
DELISTED
ContraFect Corporation
CFRX
| $17.5M | 0.66% |
3,972,300
+160,000
| +4% | +$704K |
|
|
SLN
42
Silence Therapeutics
SLN
$235M
| $17M | 0.64% |
666,666
| – | – |
|
|
GRTS
43
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $16.7M | 0.63% |
1,826,494
-34,745
| -2% | -$317K |
|
44
Sutro Biopharma
STRO
$83.1M
| $15.4M | 0.58% |
826,825
| – | – |
|
|
CALA
45
DELISTED
Calithera Biosciences, Inc
CALA
| $15.3M | 0.57% |
7,299,331
+1,732,641
| +31% | +$3.62M |
|
46
Elicio Therapeutics
ELTX
$168M
| $13.5M | 0.51% |
1,036,500
+161,500
| +18% | +$2.1M |
|
47
Immunovant
IMVT
$2.85B
| $13.5M | 0.5% |
1,273,516
+129,500
| +11% | +$1.37M |
|
48
Cogent Biosciences
COGT
$1.81B
| $12.4M | 0.47% |
1,532,282
| – | – |
|
49
MEI Pharma
MEIP
$149M
| $10.1M | 0.38% |
3,532,057
-56,098
| -2% | -$160K |
|
50
Corvus Pharmaceuticals
CRVS
$428M
| $9.82M | 0.37% |
3,678,626
+449,200
| +14% | +$1.2M |
|